Feedback on bevacizumab consultation

About this form

Please note:

You cannot save your progress.
The form does not register text formatting, such as bold or hyperlinks.
There is no character limit on any field.
You should receive an email with a summary of your feedback when you submit the form.

Do you have any comments or feedback you would like to provide about the proposal?

Do you have any comments or feedback you would like to provide about the special authority criteria and its use in clinical practice?

Do you think the proposed criteria would capture the people intended for funded access to bevacizumab? If no, please explain the changes we should consider?

What support or resources would people who are currently being treated with bevacizumab for recurrent respiratory papillomatosis need to assist them with a brand change to the Vegzelma brand?

What support or resources would prescribers of bevacizumab for recurrent respiratory papillomatosis need to assist them with a brand change to the Vegzelma brand?

For use of bevacizumab for ocular conditions, do you have any feedback on a funded option of a biosimilar?

What support or resources would health care professionals need to assist in prescribing/ dispensing bevacizumab?

What information would be needed to support people using or accessing bevacizumab, including information from a cultural perspective?

Are you submitting this response on behalf of an organisation

Your name

Your email

This is a required field but you can leave the default text in this box if you do not wish to give your email.

Your role

Your organisation

Your feedback may be shared

When you give feedback on a consultation, your feedback becomes official information that Pharmac holds. Pharmac has legal responsibilities for how we manage this official information, under laws such as the Official Information Act and Privacy Act.

Pharmac may receive a request from people for official information, which could include your feedback. Legally, Pharmac must consider whether your feedback should be released.

We will consider your views when assessing whether the feedback has to be released.

If your feedback is proposed for release, then Pharmac will contact you, unless there is a legal reason that we can't.

Note that Pharmac collects and holds your information in line with our Privacy Statement.

Tell us if there is anything about your feedback that you would prefer wasn’t released.